Posted in | News | Business | Electronics

Tianma Microelectronics Acquires Multiple Production Lines

In a move to strengthen its position as a leading supplier in the LCD marketplace, Tianma Microelectronics Co., Ltd., Shenzhen, China, has completed the acquisition of its five production lines in Japan, Shenzhen, Shanghai and Wuhan, and increased its investment in its Chengdu facility.

After this restructuring, Tianma will own 100% shares of Shanghai Tianma, Wuhan Tianma, Shanghai AVIC, and Shenzhen AVIC (2 lines), and 70% shares of Chengdu Tianma. Prior to this, Tianma Microelectronics Co., Ltd. had held controlling interests in the six lines. As a result of the stock acquisitions, the combined assets of the company are expected to surpass RMB 10 billion (USD 1.6 billion).

This consolidation of the company’s fabrication line assets will optimize product planning and production, increasing efficiency and creating more flexibility in customer support, including faster response times and time to market. The company will have all operations from front- to back-end completely in-house for its state-of-the-art STN-LCD, CSTN-LCD, TFT-LCD, AMOLED, and CF production lines. A major part of Tianma Microelectronics’ strategy is to strengthen its position as a Tier One supplier to the American marketplace.

“As we work to expand our market presence in the Americas and to provide the best support to our customers, we are very excited to see strong corporate efforts to optimize our operations and strengthen the company structure,” said Lesa Qu, President of Tianma NLT America, Inc. “We feel that these efforts will lead to substantial improvements in the level of service we can provide to our customers by taking advantage of improved production flexibility, gains in efficiency and a faster decision-making process.”

For more information, contact Tianma NLT America, Inc., 2801 Scott Blvd., Santa Clara, CA 95050. 1-408-816-7010; [email protected]; www.tianma-nlt.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.